Efficient introduction of specific homozygous and heterozygous mutations using CRISPR/Cas9
The DOI matches its Crossref record; 48 of the 49 references it cites were found in a registry or an index.
Abstract
The bacterial CRISPR/Cas9 system allows sequence-specific gene editing in many organisms and holds promise as a tool to generate models of human diseases, for example, in human pluripotent stem cells. CRISPR/Cas9 introduces targeted double-stranded breaks (DSBs) with high efficiency, which are typically repaired by non-homologous end-joining (NHEJ) resulting in nonspecific insertions, deletions or other mutations (indels). DSBs may also be repaired by homology-directed repair (HDR) using a DNA repair template, such as an introduced single-stranded oligo DNA nucleotide (ssODN), allowing knock-in of specific mutations. Although CRISPR/Cas9 is used extensively to engineer gene knockouts through NHEJ, editing by HDR remains inefficient and can be corrupted by additional indels, preventing its widespread use for modelling genetic disorders through introducing disease-associated mutations. Furthermore, targeted mutational knock-in at single alleles to model diseases caused by heterozygous mutations has not been reported. Here we describe a CRISPR/Cas9-based genome-editing framework that allows selective introduction of mono- and bi-allelic sequence changes with high efficiency and accuracy. We show that HDR accuracy is increased dramatically by incorporating silent CRISPR/Cas-blocking mutations along with pathogenic mutations, and establish a method termed 'CORRECT' for scarless genome editing. By characterizing and exploiting a stereotyped inverse relationship between a mutation's incorporation rate and its distance to the DSB, we achieve predictable control of zygosity. Homozygous introduction requires a guide RNA targeting close to the intended mutation, whereas heterozygous introduction can be accomplished by distance-dependent suboptimal mutation incorporation or by use of mixed repair templates. Using this approach, we generated human induced pluripotent stem cells with heterozygous and homozygous dominant early onset Alzheimer's disease-causing mutations in amyloid precursor protein (APP(Swe)) and presenilin 1 (PSEN1(M146V)) and derived cortical neurons, which displayed genotype-dependent disease-associated phenotypes. Our findings enable efficient introduction of specific sequence changes with CRISPR/Cas9, facilitating study of human disease.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“While exogenous DNA can be inserted at the target site through homology-directed repair (HDR) mechanism, successful insertion of exogenous DNA is relatively rare and is likely accompanied by loss of the second allele24.”
From One-step generation of tumor models by base editor multiplexing in adult stem cell-derived organoids (2023) · cites this paper as [24]
In the citing paper
“Briefly, the majority of a HDR template’s homology arm sequences are not incorporated with on-target HDR integrations (Paquet et al., 2016)”
From Pooled Knockin Targeting for Genome Engineering of Cellular Immunotherapies (2020) · cites this paper as Paquet et al., 2016
Citations
Cites
Fast and accurate short read alignment with Burrows-Wheeler transform
Li, H., & Durbin, R. (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp324 · Cited by 58,607
Multiplex Genome Engineering Using CRISPR/Cas Systems
Cong, L., Ran, F. A., Cox, D., Lin, S., Barretto, R., Habib, N., Hsu, P. D., Wu, X., Jiang, W., Marraffini, L. A., et al. (2013) · Science · doi:10.1126/science.1231143 · Cited by 15,339
Fast and accurate long-read alignment with Burrows-Wheeler transform.
Li, H., & Durbin, R. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btp698 · Cited by 12,063
RNA-Guided Human Genome Engineering via Cas9
Mali, P., Yang, L., Esvelt, K. M., Aach, J., Guell, M., DiCarlo, J. E., Norville, J. E., & Church, G. M. (2013) · Science · doi:10.1126/science.1232033 · Cited by 9,210
Development and Applications of CRISPR-Cas9 for Genome Engineering
Hsu, P. D., Lander, E. S., & Zhang, F. (2014) · Cell · doi:10.1016/j.cell.2014.05.010 · Cited by 5,762
PEAR: a fast and accurate Illumina Paired-End reAd mergeR
Zhang, J., Kobert, K., Flouri, T., & Stamatakis, A. (2014) · Bioinformatics · doi:10.1093/bioinformatics/btt593 · Cited by 4,497
Wang, H., Yang, H., Shivalila, C. S., Dawlaty, M. M., Cheng, A. W., Zhang, F., & Jaenisch, R. (2013) · Cell · doi:10.1016/j.cell.2013.04.025 · Cited by 3,495
Goecks, J., Nekrutenko, A., Taylor, J., & The Galaxy Team (2010) · Genome Biology · doi:10.1186/gb-2010-11-8-r86 · Cited by 3,453
Double nicking by RNA-guided CRISPR Cas9 for enhanced genome editing specificity
Ran, F. A., Hsu, P. D., Lin, C.-Y., Gootenberg, J. S., Konermann, S., Trevino, A. E., Scott, D. A., Inoue, A., Matoba, S., Zhang, Y., et al. (2013) · Cell · doi:10.1016/j.cell.2013.08.021 · Cited by 3,299
High-Frequency off-Target Mutagenesis Induced by CRISPR-Cas Nucleases in Human Cells
Fu, Y., Foden, J. A., Khayter, C., Maeder, M. L., Reyon, D., Joung, J. K., & Sander, J. D. (2013) · Nature Biotechnology · doi:10.1038/nbt.2623 · Cited by 3,292
Cited by
Items 701–800 of 935
Battaglia, R. A., Bolshakova, S., Mazureac, I., Liyanage, D., Pettinari, N. L., Johnson, A., Crouse, E., Habib, S., Flessas, I., Nadig, A., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.11.08.687374 · Cited by 3
Bacterial directed evolution of CRISPR base editors
Mach, R. Q., & Miller, S. M. (2025) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/bs.mie.2025.01.003 · Cited by 3
Generation of albino C57BL/6J mice by CRISPR embryo editing of the mouse tyrosinase locus
Diril, M. K., Esmen, K., Sehitogullari, T., & Öztürk, G. (2025) · Journal of Genetics · doi:10.1007/s12041-025-01493-1 · Cited by 2
Targeting TDP-43 Proteinopathy in hiPSC-Derived Mutated hNPCs with Mitoxantrone Drugs and miRNAs
Ansari, U. A., Srivastava, A., Srivastava, A. K., Pandeya, A., Vatsa, P., Negi, R., Singh, A., & Pant, A. B. (2025) · Pharmaceutics · doi:10.3390/pharmaceutics17040410 · Cited by 2
“To the best of our knowledge, this study is the first to elucidate the protective effect of Mitoxantrone, along with the microRNA, in the TDP43-mutated ALS model.”
Zhao, C., Cao, Y., Ibrahim, N., Wang, Y., & Martemyanov, K. A. (2025) · Nature Communications · doi:10.1038/s41467-025-58945-6 · Cited by 3
ARROW: Allele-Specific Recombined gRNA Design for Reduced Off-Target with Enhanced Specificity
Bae, T., Been, K. W., Kang, S., Hong, S., Hur, J. K., & Hwang, W. (2025) · Bioengineering · doi:10.3390/bioengineering12111237 · Cited by 2
Dual-single-guide RNA strategy improves CRISPR-mediated homology-directed repair in Aspergillus
Fu, M., Wang, J., Li, J., Zhou, Y., Huang, X., Jia, Z., Luo, Y., Tan, X., Gao, Y., Yu, B., et al. (2026) · Nucleic Acids Research · doi:10.1093/nar/gkag095 · Cited by 2
“[ 37 ], which demonstrated that HDR efficiency is inversely related to the distance between the Cas9 cleavage site and the desired mutation.”
Hayes, K. M., Boldt, K., Schnorr, P. J., Bawa, P., Abyazi, M. L., Ware, M. S., Gyimesi, G., James, M. F., Ko, H., Cunningham‐Rundles, C., et al. (2026) · JCI Insight · doi:10.1172/jci.insight.198703 · Cited by 2
“CRISPR/Cas9-mediated gene editing can introduce or correct genetic variants in iPSCs, which then can be differentiated into disease-relevant cells of interest for further investigation (20–22).”
孔令芸, Xin, C., Cheng, M., Ma, S., Zheng, Z., Chen, J., & Zhou, X. (2026) · Eye Discovery · doi:10.1016/j.edisc.2026.100040 · Cited by 2
Klimmt, J., Gonçalves, C. C., Montgomery, J. V., Müller, S. A., Bublitz, M., Filser, S., Paeger, L., Nuscher, B., Dannert, A., Roeber, S., et al. (2026) · Nature Neuroscience · doi:10.1038/s41593-026-02367-0 · Cited by 4
Self-citationProgrammable RNA-Guided DNA Recombination: Mechanisms, Engineering, and Applications
Agha, A. S. A. A., Hattab, D., Bakhtiar, A., Khatib, A. O. A., Abushahla, H. S., Alketbi, S., & Akour, A. A. (2026) · Biomedicines · doi:10.3390/biomedicines14092008 · Cited by 2
“Paquet et al. used CRISPR–Cas9 to introduce precise heterozygous and homozygous mutations into human induced pluripotent stem cells, generating Alzheimer’s disease models that reproduced genotype-dependent neuronal phenotypes [63].”
Small RNA-mediated prevention, diagnosis and therapies of cancer
Hasan, A. A., & Azam, A. T. M. Z. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-813669-0.00009-9 · Cited by 3
Moore, A. L., Marshall, C. D., Nauta, A., Lorenz, H. P., & Longaker, M. T. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-809880-6.00005-9 · Cited by 2
Autophagic processes in early- and late-onset Alzheimer's disease
Xie, C., Aman, Y., Frank, J., Lagartos-Donate, M. J., Gudmundsrud, R., Čechová, K., Shi, L., Vyhnálek, M., & Fang, E. F. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-822003-0.00012-7 · Cited by 2
CRISPR Manipulations in Stem Cell Lines
Chang, Y., Cui, X., Levi, S. R., Jenny, L. A., & Tsang, S. H. (2022) · Methods in molecular biology · doi:10.1007/978-1-0716-2651-1_23 · Cited by 2
Genome editing pig models with elements for controllable gene expression
Jin, Q., Shi, H., Liu, X., Ju, J., Wang, K., & Lai, L. (2023) · Animal Research and One Health · doi:10.1002/aro2.20 · Cited by 2
Scarless genome editing technology and its application to crop improvement
Ikeda, K. (2024) · Ikushugaku zasshi · doi:10.1270/jsbbs.23045 · Cited by 2
Lee, K. S., Lee, T., Kim, M., Ignatova, E., Ban, H., Sung, M. K., Kim, Y., Kim, Y., Han, J., & Choi, J. K. (2025) · Scientific Reports · doi:10.1038/s41598-024-83839-w · Cited by 3
Investigation of ABCA4 Missense Variants and Potential Small Molecule Rescue in Retinal Organoids
Piccolo, D., Sladen, P. E., Guarascio, R., Ziaka, K., & Cheetham, M. E. (2025) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.66.9.58 · Cited by 2
IVNS1ABP mutation drives cellular senescence in newly identified progeroid neuropathy
Yuan, F., Tan, Y. S., Wang, H., Ali, A. N., Yuan, Q., Chou, S.-M., Yen, Y., Narayanan, G., Zhou, L., Shboul, M., et al. (2026) · Nature Communications · doi:10.1038/s41467-026-70756-x · Cited by 2
Bioengineering Strategies to Develop Podocyte Culture Systems
Williams, S., Charest, J. L., Pollak, M. R., & Subramanian, B. (2021) · Tissue Engineering Part B Reviews · doi:10.1089/ten.teb.2021.0154 · Cited by 2
Genome Editing of Erythroid Cell Culture Model Systems
Yik, J. J., Crossley, M., & Quinlan, K. G. R. (2017) · Methods in molecular biology · doi:10.1007/978-1-4939-7428-3_15 · Cited by 2
Imaging pathological activities of human brain tissue in organotypic culture
Savary, E. (2018) · Journal of Neurological Disorders · doi:10.4172/2329-6895-c9-049 · Cited by 2
A review of application of base editing for the treatment of inner ear disorders
Zhao, X., Sun, Z., Kang, W., Tao, Y., & Wu, H. (2019) · Journal of Bio-X Research · doi:10.1097/jbr.0000000000000040 · Cited by 2
[Chromosomal large fragment deletion induced by CRISPR/Cas9 gene editing system].
Cheng, L., Liu, Y., & Niu, T. (2017) · PubMed Central · doi:10.3760/cma.j.issn.0253-2727.2017.05.014 · Cited by 2
Maximizing the Efficacy of CRISPR/Cas Homology-Directed Repair Gene Targeting
Elton, T. S., Hossain, M. I., Carvajal‐Moreno, J., Wang, X., Skaggs, D. J., & Yalowich, J. C. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.109051 · Cited by 2
Programmed genome editing of the omega-1 ribonuclease 1 of the blood fluke, Schistosoma mansoniPreprint
Ittiprasert, W., Mann, V. H., Karinshak, S. E., Coghlan, A., Rinaldi, G., Sankaranarayanan, G., Chaidee, A., Tanno, T., Kumkhaek, C., Prangtaworn, P., et al. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/358424 · Cited by 3
Rapid discovery of synthetic DNA sequences to rewrite endogenous T cell circuitsPreprint
Roth, T. L., Li, P. J., Nies, J. F., Yu, R., Nguyen, M. L. T., Lee, Y., Apathy, R., Truong, A., Hiatt, J. B., Wu, D., et al. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/604561 · Cited by 2
Rebs, S. (2021) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-8399 · Cited by 2
Impact assessment of exploratory wells offshore south Florida
Shinn, E. A., Lidz, B. H., & Dustan, P. (1989) · doi:10.67297/000bae · Cited by 4
Cell type-specific epigenomic variation and its association with genotype in the human breastPreprint
Hauduc, A., Steif, J., Bilenky, M., Moksa, M., Cao, Q., Ding, S., Eaves, C. J., & Hirst, M. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.04.16.648998 · Cited by 3
Sex-specific Genetic Regulatory Effects in ChickensPreprint
Zhang, H., Lin, B., Xi, Y., Zhu, D., Peng, C., Tu, J., Liu, H., Guan, D., Ouyang, Q., Liu, B., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.02.26.708179 · Cited by 4
O’Neill, T. J., Krappmann, D., & Gewies, A. (2022) · BIO-PROTOCOL · doi:10.21769/bioprotoc.4423 · Cited by 1
Wang, X., Carvajal‐Moreno, J., Zhao, X., Li, J., Hernandez, V. A., Yalowich, J. C., & Elton, T. S. (2024) · Molecular Pharmacology · doi:10.1124/molpharm.124.000868 · Cited by 1
Recurrent Increased Nuchal Translucency Led to the Identification of Novel NUP107 Variants
Atallah, I., Cisarova, K. V., Guenot, C., Dubruc, E., Superti‐Furga, A., Campos‐Xavier, B., & Unger, S. (2024) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.63920 · Cited by 1
“One possible approach is the use of CRISPR/Cas9 editing technology to test the viability of the variants in a homozygous state (Paquet et al. 2016).”
Mouse and human T cell Cas9-RNP/nucleofection-mediated gene-editing
Sohn, M., Pantsulaia, G., & Brody, J. (2025) · Methods in cell biology · doi:10.1016/bs.mcb.2025.03.020 · Cited by 2
Shi, X., Lu, S., Tang, Q., & Zhao, X. (2025) · Human Genomics · doi:10.1186/s40246-025-00820-y · Cited by 1
“To validate the effects of the candidate sites AA(- 9, -10)TT and A18G in vivo, we used HDR-mediated CRISPR/Cas9 technology to construct mutant endogenous cell models [50–52].”
Velangani, H. G., Ghosh, A., Singh, S., & Kiran, S. (2026) · BMC Genomics · doi:10.1186/s12864-025-12406-y · Cited by 2
“These short oligos or oligodeoxynucleotides (ODNs) have been effectively utilized as donor templates for introducing small genomic edits with CRISPR at the target genome [41].”
Potential of CRISPR/Cas9 Genome Engineering for Biofuel Production From Economically Relevant Algae
Kumari, S., Phillips, A. J., Adelodun, B., Maria, F. D., Sundaramurthy, S. K., & Pal, T. (2026) · International Journal of Energy Research · doi:10.1155/er/2368855 · Cited by 3
GFP reporter system reveals cell-to-cell variability in aquaporin-2 expression
Chen, L., Murillo‐de‐Ozores, A. R., Park, E., Ou, S., & Knepper, M. A. (2026) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00936.2025 · Cited by 1
Xu, Y. R., Tao, Y., Lish, A. M., Li, S., Ostaszewski, B. L., Anderson, A. K., Young‐Pearse, T. L., Lawton, T., Yang, H., Walsh, D. M., et al. (2026) · Annals of Neurology · doi:10.1002/ana.78196 · Cited by 2
You, H.-J., Kim, G.-Y., & Kang, M. (2026) · Scientific Reports · doi:10.1038/s41598-026-45234-5 · Cited by 1
“Nevertheless, previous studies have demonstrated that CRISPR/Cas9-mediated knock-in events typically yield a higher frequency of heterozygous clones than homozygous clones, with the latter being particularly difficult to isolate 23,24 .”
Overcoming the challenges of genome-editing essential genes
Teboul, L., & Davies, B. (2026) · STAR Protocols · doi:10.1016/j.xpro.2026.104672 · Cited by 1
“39 Although this approach has never been systematically tested in a similar manner in mouse zygotes, the design principles would be very applicable to mouse engineering, when trying to generate heterozygous knockin mice and potentially avoiding the manifestation of phenotypes in the founder…”
Integrative Research of Induction of Pluripotent Stem Cells
Gao, P., Sun, C., Liao, W., Jiang, W., Liu, T., & Pan, W. (2017) · Integrative Medicine International · doi:10.1159/000479182 · Cited by 1
Lee, N., Ha, D.-I., Ko, J., & Kim, Y.-S. (2020) · Molecular and Cellular Probes · doi:10.1016/j.mcp.2020.101675 · Cited by 1
Bandyopadhyay, S., Douglass, J., Kapell, S., Khan, N., Feitosa-Suntheimer, F., Klein, J. A., Temple, J., Brown-Culbertson, J., Tavares, A. H., Saeed, M., et al. (2021) · G3 Genes Genomes Genetics · doi:10.1093/g3journal/jkab169 · Cited by 1
Genetically Engineered Animal Models in Toxicologic Research
Himmel, L. E., Wilson, K. L., Santagostino, S. F., & Bolon, B. N. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-821044-4.00024-8 · Cited by 1
Reprogramming of Human B Cells from Secreting IgG to IgM by Genome Editing
Lin, G., Zhang, K., Han, Y., Peng, R., Zhang, J., Li, D., & Li, J. (2022) · The CRISPR Journal · doi:10.1089/crispr.2021.0093 · Cited by 1
CRISPR Technology - Recent Advances
Chen, Y. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.102156 · Cited by 2
Mittal, K. R., Jain, N., Mittal, S., & Jain, C. K. (2023) · Current Psychiatry Research and Reviews · doi:10.2174/2666082219666230320151355 · Cited by 1
Gene Editing Tool for Neurodegenerative Diseases
Khan, M. Y., Khan, H., Maarfi, F., Khanam, A., Hasan, Z., & Husain, A. (2024) · Springer eBooks · doi:10.1007/978-981-99-9404-5_16 · Cited by 4
Ametrano, A., Miranda, B., Moretta, R., Dardano, P., Stefano, L. D., Oreste, U., & Coscia, M. R. (2024) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2024.1315633 · Cited by 1
Aoki, Y. (2024) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2024.102330 · Cited by 1
CRISPR/Cas9 gene editing: A new hope for Parkinson's disease
Hanjankar, S. N., Haria, A., Agarwal, R., & Patravale, V. B. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-23841-3.00023-6 · Cited by 1
Development of capability for genome‐scale CRISPR‐Cas9 knockout screens in New Zealand
Hunter, F. W., Tsai, P., Kakadia, P. M., Bohlander, S. K., Print, C. G., & Wilson, W. R. (2017) · Journal of the Royal Society of New Zealand · doi:10.1080/03036758.2017.1400984 · Cited by 1
“reengineered to seek out and manipulate genes in living cells (including higher eukaryotes) providing techniques for precise re-writing of DNA sequences (gene editing) (Komor et al. 2016; Paquet et al. 2016), inactivating genes (gene knockout) (Kleinstiver et al.”
BackgroundInduced pluripotent stem cells for modeling of X-linked dystonia-parkinsonism
Raković, A., Weißbach, A., Seibler, P., & Klein, C. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-85764-2.00008-9 · Cited by 1
Delivery Methods for CRISPR/Cas Reagents
Ashraf, S., Munawar, N., Zahoor, M. K., Jamil, A., Hammad, M., Ghaffar, A., & Ahmad, A. (2021) · Springer eBooks · doi:10.1007/978-981-16-6305-5_4 · Cited by 2
Xu, W., Zuo, Q., Feng, D., He, C., Lin, C., Huang, D., Wan, Y., Chen, F., Mo, G., Sun, Q., et al. (2022) · Current Issues in Molecular Biology · doi:10.3390/cimb44040116 · Cited by 1
“Meanwhile, a PAM-altering synonymous point mutation was introduced in the reporter to improve HDR efficiency [33].”
BackgroundContemporaneous sample data tracking for the generation of genome edited cell lines
Plant, A. L., Halter, M. W., Stinson, J. R., & Greene, G. (2022) · Scientific Reports · doi:10.1038/s41598-022-24928-6 · Cited by 1
Gene Editing in Hematopoietic Stem Cells
Liao, J., & Wu, Y. (2023) · Advances in experimental medicine and biology · doi:10.1007/978-981-99-7471-9_11 · Cited by 4
Variant Interpretation and Genomic Medicine
Carss, K., Goldstein, D. B., Aggarwal, V. S., & Petrovski, S. (2019) · Wiley eBooks · doi:10.1002/9781119487845.ch27 · Cited by 1
The role of phagocytosis-dependent activation of TFEB in the clearance of salmonella
Escobar, E. O. (2021) · doi:10.32920/ryerson.14655972.v1 · Cited by 1
Charting Single Cell Lineage Dynamics and Mutation Networks via Homing CRISPRPreprint
Wang, L., Dong, W., Yin, Z., Sheng, J., Ezeana, C. F., Li, Y., Yu, X., Wong, S. S. Y., Wan, Z., Danforth, R. L., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.01.05.574236 · Cited by 1
Highly efficient and scarless genome editing via essential-gene-coupled homology-directed repairPreprint
Yeo, J. H., Kim, H. H., Oh, S. H., & Lee, J. (2026) · Genome Research · doi:10.1101/gr.281194.125 · Cited by 1
A CORRECT step forward in disease modelling
Koch, L. (2016) · Nature Reviews Genetics · doi:10.1038/nrg.2016.60
Characterising mechanisms of aberrant androgen receptor signalling in advanced prostate cancer
Guo, W., Robson, C. N., & Gaughan, L. (2016) · Endocrine Abstracts · doi:10.1530/endoabs.42.p23
Revilla, A. (2017) · Journal of Stem Cell Research & Therapeutics · doi:10.15406/jsrt.2017.02.00060
Palmer, C. N. A. (2017) · Digital Access to Scholarship at Harvard (DASH) (Harvard University)
Liao, D., Luo, D., Li, Y., Hu, Z., Yin, Y., He, R., Hu, J., Luo, W., Li, J., Wen, G., et al. (2017) · Cancer translational medicine · doi:10.4103/ctm.ctm_22_17
Using an activator of hERG (RPR-260245) in a model of acquired and inherited Long QT syndrome type 2
Sergeev, V. (2017) · Summit (Simon Fraser University)
Genome Editing During Development Using the CRISPR-Cas Technology
Arzate‐Mejía, R. G., Licona-Limón, P., & Targa, F. R. (2018) · Methods in molecular biology · doi:10.1007/978-1-4939-7714-7_16 · Cited by 1
At the Bench-Familial Alzheimer's Disease
Hurley, D. (2018) · Neurology Today · doi:10.1097/01.nt.0000530365.57551.9b
Lessons From Using Genome Editing to Create a Faithful Model of a Novel Congenital Anemia
Mi, X. (2018) · Digital Access to Scholarship at Harvard (DASH) (Harvard University)
The Nai Fellow Profile: An Interview with Dr. Marc Tessier-Lavigne
Tessier‐Lavigne, M., & Macuare, K. A. (2018) · Technology & Innovation · doi:10.21300/20.1-2.2018.147
Self-citationKha, M. (2019) · Chalmers Publication Library (Chalmers University of Technology)
Sampaio, I. S. (2019) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.42.2019.tde-29042019-102850
Disease in a Dish: Cellular Models to Understand Human Conditions
Tidball, A. M. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-816573-7.00002-x · Cited by 2
Genetic modification in CPVT patient specific induced pluripotent stem cells with CRISPR/Cas9
Zimmermann, M. (2019) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-7693
Jínek, M. (2019) · The CRISPR Journal · doi:10.1089/crispr.2019.29079.mji
Structural variants in the great tit genome and their effect on seasonal timing
da Silva, V. H. (2020) · doi:10.18174/512907 · Cited by 3
Pathways of neurodegeneration underlying dementia
Buckley, N. J., & Tofaris, G. K. (2020) · doi:10.1093/med/9780198713005.003.0038
Fu, X., Lui, K. N.-C., Tang, C. S.-M., Ng, R. K., Lai, F. P.-L., Lau, S.-T., Li, Z., Gracia-Barcelo, M.-M., Sham, P. C., Tam, P. K. H., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.04.08.032045
Gene editing and central nervous system regeneration
Lopes, S. M., & de Almeida, L. P. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-818084-6.00011-8
Understanding the Cellular Consequences of Meier-Gorlin Syndrome
Sullivan, R. K. E. (2020) · Otago University Research Archive (University of Otago)
Mayers, J. G. (2019) · TSpace (University of Toronto) · Cited by 1
Programmable downsizing of CRISPR-Cas9 activity for precise and safe genome editingPreprint
Kawamata, M., Suzuki, H. I., Kimura, R., & Suzuki, A. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.10.31.361733
Mechanisms of Centriole Duplication and Spindle Assembly in Human Cells
Wu, Q. (2019) · TSpace (University of Toronto) · Cited by 1
3D microenvironments for in vitro modeling of alzheimer’s disease
Ranjan, V. (2020) · DR-NTU (Nanyang Technological University) · doi:10.32657/10356/146832
Combining bioscaffolds and iPSCs in the treatment of neural trauma and Alzheimer’s disease
Brice, R., Kehler, J., & Yao, L. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-85766-6.00007-3
Hao, J. (2017) · Cited by 1
Christidi, E. (2021) · cIRcle (University of British Columbia) · doi:10.14288/1.0402336
Sproul, A. A. (2022) · CRISPR Genome Surgery in Stem Cells and Disease Tissues · doi:10.1016/b978-0-12-817876-8.00002-4
Self-citationUsher, I., Ligammari, L., Ahrabi, S., Hepburn, E., Connolly, C., Bond, G. L., Flanagan, A. M., & Cottone, L. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.11.12.467071
“Combined reads are those that contain indels and the desired mutation (also known as mixed repair reads, see [5]).”
BackgroundMethodResultInfluentialHuman induced pluripotent stem cell modeling of neurofibromatosis type 1
Schurr, S. V., Hartigan, K. A., & Gutmann, D. H. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-85765-9.00008-4
Application of CRISPR/Cas system in iPSC-based disease model of hereditary deafness
Giri, S., & Malgrange, B. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-85767-3.00009-8
Majer, F., Asfaw, B., Kuchař, L., Mušálková, D., Mrazova, L. S., Dobrovolný, R., Ledvinová, J., & Hřebı́ček, M. (2022) · Journal of Inherited Metabolic Disease · doi:10.1002/jimd.12481
Development and Vision of CRISPR-Based Technology
Zhang, Z., Wang, P., & Liu, J. (2022) · Springer eBooks · doi:10.1007/978-981-16-8504-0_1
Extension and Improvement of CRISPR-Based Technology
Zhang, Z., Wang, P., & Liu, J. (2022) · Springer eBooks · doi:10.1007/978-981-16-8504-0_3
Metadata
- Authors
- Paquet, D., Kwart, D., Chen, A., Sproul, A., Jacob, S., Teo, S., Olsen, K. M., Gregg, A., Noggle, S., & Tessier-Lavigne, M.
- Affiliations
- Rockefeller University (US)
- New York Stem Cell Foundation (US)
- Cornell University (US)
- Venue
- Nature
- Published
- 2016-04-27
- Volume
- 533
- Issue
- 7601
- Pages
- 125-129
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2343876552
- Cited by
- 951
- References
- 49
- Citations by year
- 2026: 58 · 2025: 56 · 2024: 90 · 2023: 87 · 2022: 104 · 2021: 106 · 2020: 125 · 2019: 93 · 2018: 111 · 2017: 91 · 2016: 29
- FWCI
- 56.11
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- Howard Hughes Medical Institute
- National Institutes of Health (UL1TR000043)
- National Institute of General Medical Sciences (T32GM007739)
- National Center for Advancing Translational Sciences
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA regulation and disease
- Keywords
- CRISPR/Cas9, homology-directed repair, non-homologous end joining, amyloid precursor protein, presenilin 1, early-onset Alzheimer's disease, induced pluripotent stem cells, disease modeling
- MeSH terms
- RNA, Guide, CRISPR-Cas Systems, Adolescent, Alleles, Alzheimer Disease, Animals, Base Sequence, DNA Repair, Female, Genes, Dominant, Genetic Engineering, Heterozygote, Homozygote, Humans, Male, Mutation, Substrate Specificity, Templates, Genetic, Mutagenesis, Amyloid beta-Protein Precursor, Sequence Homology, Age of Onset, Mice, Presenilins, DNA Cleavage, DNA Breaks, Double-Stranded, Genetic Association Studies, Induced Pluripotent Stem Cells, CRISPR-Cas Systems
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.